Evidence and Mechanisms of Fat Depletion in Cancer
The majority of cancer patients experience wasting characterized by muscle loss with or without fat loss. In human and animal models of cancer, body composition assessment and morphological analysis reveals adipose atrophy and presence of smaller adipocytes. Fat loss is associated with reduced quali...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-11-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6643/6/11/5280 |
id |
doaj-a5aa9b4dd7b744e298bef7c9aacfec9e |
---|---|
record_format |
Article |
spelling |
doaj-a5aa9b4dd7b744e298bef7c9aacfec9e2020-11-24T22:22:24ZengMDPI AGNutrients2072-66432014-11-016115280529710.3390/nu6115280nu6115280Evidence and Mechanisms of Fat Depletion in CancerMaryam Ebadi0Vera C. Mazurak1Division of Human Nutrition, Department of Agricultural, Food and Nutritional Science, University of Alberta, 4-002 Li Ka Shing Centre for Health Research Innovation, Edmonton, AB T6G 2E1, CanadaDivision of Human Nutrition, Department of Agricultural, Food and Nutritional Science, University of Alberta, 4-002 Li Ka Shing Centre for Health Research Innovation, Edmonton, AB T6G 2E1, CanadaThe majority of cancer patients experience wasting characterized by muscle loss with or without fat loss. In human and animal models of cancer, body composition assessment and morphological analysis reveals adipose atrophy and presence of smaller adipocytes. Fat loss is associated with reduced quality of life in cancer patients and shorter survival independent of body mass index. Fat loss occurs in both visceral and subcutaneous depots; however, the pattern of loss has been incompletely characterized. Increased lipolysis and fat oxidation, decreased lipogenesis, impaired lipid depositionand adipogenesis, as well as browning of white adipose tissue may underlie adipose atrophy in cancer. Inflammatory cytokines such as interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), and interleukin-1 beta (IL-1β) produced by the tumor or adipose tissue may also contribute to adipose depletion. Identifying the mechanisms and time course of fat mass changes in cancer may help identify individuals at risk of adipose depletion and define interventions to circumvent wasting. This review outlines current knowledge of fat mass in cancer and illustrates the need for further studies to assess alterations in visceral and subcutaneous adipose depots and possible mechanisms for loss of fat during cancer progression.http://www.mdpi.com/2072-6643/6/11/5280adipose tissuecancercomputed tomographyfat mobilization |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Maryam Ebadi Vera C. Mazurak |
spellingShingle |
Maryam Ebadi Vera C. Mazurak Evidence and Mechanisms of Fat Depletion in Cancer Nutrients adipose tissue cancer computed tomography fat mobilization |
author_facet |
Maryam Ebadi Vera C. Mazurak |
author_sort |
Maryam Ebadi |
title |
Evidence and Mechanisms of Fat Depletion in Cancer |
title_short |
Evidence and Mechanisms of Fat Depletion in Cancer |
title_full |
Evidence and Mechanisms of Fat Depletion in Cancer |
title_fullStr |
Evidence and Mechanisms of Fat Depletion in Cancer |
title_full_unstemmed |
Evidence and Mechanisms of Fat Depletion in Cancer |
title_sort |
evidence and mechanisms of fat depletion in cancer |
publisher |
MDPI AG |
series |
Nutrients |
issn |
2072-6643 |
publishDate |
2014-11-01 |
description |
The majority of cancer patients experience wasting characterized by muscle loss with or without fat loss. In human and animal models of cancer, body composition assessment and morphological analysis reveals adipose atrophy and presence of smaller adipocytes. Fat loss is associated with reduced quality of life in cancer patients and shorter survival independent of body mass index. Fat loss occurs in both visceral and subcutaneous depots; however, the pattern of loss has been incompletely characterized. Increased lipolysis and fat oxidation, decreased lipogenesis, impaired lipid depositionand adipogenesis, as well as browning of white adipose tissue may underlie adipose atrophy in cancer. Inflammatory cytokines such as interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), and interleukin-1 beta (IL-1β) produced by the tumor or adipose tissue may also contribute to adipose depletion. Identifying the mechanisms and time course of fat mass changes in cancer may help identify individuals at risk of adipose depletion and define interventions to circumvent wasting. This review outlines current knowledge of fat mass in cancer and illustrates the need for further studies to assess alterations in visceral and subcutaneous adipose depots and possible mechanisms for loss of fat during cancer progression. |
topic |
adipose tissue cancer computed tomography fat mobilization |
url |
http://www.mdpi.com/2072-6643/6/11/5280 |
work_keys_str_mv |
AT maryamebadi evidenceandmechanismsoffatdepletionincancer AT veracmazurak evidenceandmechanismsoffatdepletionincancer |
_version_ |
1725768505880477696 |